Skip to main content
Premium Trial:

Request an Annual Quote

Need Cash for That Fancy New Genomic Tool? New IBM Program Will Finance Medical, Biotech Equipment

NEW YORK, Feb. 15 (GenomeWeb News) - IBM yesterday announced a new program to assist healthcare providers with the up-front costs of purchasing new medical equipment, including genomic-related technologies.

 

The program, called Progress Payment Offering for Medical Equipment Leasing, will allow customers in the healthcare industry to defray the large up-front costs associated with purchasing new medical equipment by making smaller monthly payments before the equipment is installed.

 

In a typical leasing program, IBM Global Financing will advance a large percentage of the cost of an instrument to the manufacture, and then create an interest-only loan for the purchaser for that amount.

 

According to Terry Trierweiler, a business development executive for IGF, the program was originally intended to focus on diagnostic imaging equipment because IBM identified the greatest need in that area. However, the financing program will also apply to molecular biology tools frequently used in clinical diagnostics, such as mass spectrometers, blood analyzers, pathology equipment, and gene sequencers, she said.

 

Trierweiler also said that besides the income generated from interest collected on loans, IBM will benefit by being able to target a wider range of customers within the healthcare industry.

 

The program is currently available in the US and Canada, but IBM will soon be expanding it to Europe, as well as countries in Northern Africa and the Asia-Pacific region, Trierweiler said.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.